Vimarsana
Biggest News Aggregation in the World

Page 6 - Array Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Array Biopharma Today - Breaking & Trending Today

Dilated Cardiomyopathy Market is Growing Rapidly with Value of USD 450 million by 2029 - Vimarsana News

Dilated Cardiomyopathy Market is Growing Rapidly with Value of USD 450 million by 2029

Dilated Cardiomyopathy market report gives details about historic data, present market trends, future product environment, marketing strategies, technological innovation, upcoming technologies, emerging trends or opportunities, and the technical progress in the related industry in this market research report. The re...

ABBV-011 Showcases Early Tolerability, Antitumor Activity in Small Cell Lung Cancer - Vimarsana News

ABBV-011 Showcases Early Tolerability, Antitumor Activity in Small Cell Lung Cancer

The SEZ6-targeted antibody-drug conjugate ABBV-011, when administered at 1 mg/kg every 3 weeks, was found to be well tolerated and to demonstrate early efficacy in patients with relapsed or refractory small cell lung cancer.

Global Gastric Cancer Drugs Market Report 2023: Increasing Number of Obesity Cases and the Smoking Population Drives Growth - Vimarsana News

Global Gastric Cancer Drugs Market Report 2023: Increasing Number of Obesity Cases and the Smoking Population Drives Growth

/PRNewswire/ -- The "Gastric Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...

ClinOne closes $3M series A funding led by Boulder Ventures - Vimarsana News

ClinOne closes $3M series A funding led by Boulder Ventures

A company providing a single platform to support clients’ clinical trial journeys has closed a $3 million Series A funding.

Analyzing ASLAN Pharmaceuticals (NASDAQ:ASLN) & Regulus Therapeutics (NASDAQ:RGLS) - Vimarsana News

Analyzing ASLAN Pharmaceuticals (NASDAQ:ASLN) & Regulus Therapeutics (NASDAQ:RGLS)

ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Rating) and Regulus Therapeutics (NASDAQ:RGLS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Volatility & Risk ASLAN Pharmaceuticals has a beta of […]